Home
/

What is an RDW Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

RDW measures variation in red blood cell size, reflecting whether your bone marrow is producing cells steadily or is under nutritional, inflammatory, or structural stress. Most labs consider 11–15% normal, with healthiest values in the lower-middle range; elevated RDW appears early in iron deficiency, mixed deficiencies, hemolysis, chronic inflammation, and has been linked to greater cardiovascular risk in population studies.

Read more →
Table of contents

RDW: How Uniform Your Red Cells Are in Size

Red Cell Distribution Width (RDW) is a measure of how varied the sizes of your red blood cells are. Red blood cells (erythrocytes) are made in your bone marrow, loaded with hemoglobin, and released into the bloodstream to carry oxygen for about four months. In a routine blood sample, millions of these cells are assessed for their size (cell volume). RDW summarizes the spread of those sizes—how tightly clustered they are around the average or how wide the spread is (anisocytosis).

What RDW reflects is the balance of red cell production, maturation, and survival. When the marrow produces cells steadily and supplies are stable, red cells tend to be fairly uniform. When production speeds up, slows down, or becomes uneven, the bloodstream can contain a mix of smaller and larger cells, widening the distribution. RDW therefore provides context for hemoglobin and average cell size (mean corpuscular volume, MCV), signaling how the marrow is adapting to oxygen needs, blood loss, or systemic stress. It captures the dynamic story of red cell turnover—whether new cells differ from older ones—rather than measuring any single molecule.

Why Size Variation Echoes Across Heart, Brain, and Muscles

Red Cell Distribution Width (RDW) captures how uniform—or uneven—the sizes of your red blood cells are. Because red cells carry oxygen to every organ, wide size variation signals stress in the blood-forming system and can echo problems in nutrient supply, inflammation, or marrow function that ripple across the heart, brain, muscles, and metabolism.

Inside the 11–15% Range and What Elevation Signals

Most labs consider values roughly 11–15, and the healthiest pattern typically sits in the lower–middle of that range, reflecting steady, efficient erythropoiesis. When RDW sits on the low end, red cells are strikingly uniform. This usually means hematopoiesis is stable and symptoms are absent. It rarely indicates disease; in some lifelong conditions with uniformly small cells, such as certain thalassemia traits, RDW may be normal-to-low despite anemia.

When RDW is elevated, size variation (anisocytosis) increases. That often appears early in iron deficiency, and in mixed deficiencies like iron with B12 or folate, where some cells are small and others large. It can rise with hemolysis or recovery from blood loss (many young reticulocytes), chronic inflammation, liver disease, alcohol use, or bone marrow disorders. People may notice fatigue, shortness of breath with exertion, palpitations, headaches, or cognitive fog as oxygen delivery becomes less reliable. Women with heavy menstrual bleeding and pregnant individuals—due to higher iron demand—and older adults are common groups where a high RDW has added significance. Newborns naturally show higher RDW that normalizes over infancy.

Being in range suggests balanced erythropoiesis, adequate iron/B12/folate and hormonal support, and limited inflammation, supporting steady oxygen transport. Population data link the lowest risk to the lower-to-mid part of the reference interval.

Methods, Acute Illness, and Drug Effects

Interpret RDW alongside hemoglobin, mean cell volume (MCV), reticulocytes, and smear. Labs report RDW-CV or RDW-SD; methods differ slightly. Acute illness can transiently raise RDW. In pregnancy, increases often mirror iron demand. Some medications and alcohol alter red-cell maturation.

Big picture, RDW integrates nutrient status, marrow health, and systemic inflammation. Interpreted alongside hemoglobin, MCV, ferritin, B12/folate, and reticulocyte count, it helps pinpoint the cause of anemia and also tracks overall physiologic resilience, with higher RDW linked in studies to greater cardiovascular and mortality risk over time.

What RDW Reveals About Marrow Steadiness and Long-Term Risk

RDW measures how much your red blood cells differ in size (anisocytosis). It reflects the steadiness of marrow production and maturation (erythropoiesis), which shapes oxygen delivery, energy metabolism, exercise capacity, cognition, and cardiovascular resilience. Higher RDW often signals systemic stress across diseases.

FAQs

RDW testing measures the variation in red blood cell size (anisocytosis) as part of a complete blood count. It is usually reported as RDW-CV (%) or RDW-SD (fL).

RDW can flag early iron deficiency, help classify anemia with MCV and hemoglobin, reveal B12/folate patterns, and track response to nutrient therapy over time.

Test RDW whenever you repeat a CBC or are monitoring iron, B12, or folate status. For trend tracking, intervals such as every 3–6 months are common, with more frequent checks during active treatment.

Iron, B12, and folate intake/absorption; recent bleeding or transfusion; hemolysis with reticulocytosis; liver disease; alcohol use disorder; inflammation; thyroid dysfunction; chronic illness; and age can influence RDW.

No special preparation is typically required. RDW is part of a standard CBC, and fasting is not usually necessary.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Salvagno, G. L., Sanchis-Gomar, F., Picanza, A., & Lippi, G. (2015). Red blood cell distribution width: A simple parameter with multiple clinical applications. Critical Reviews in Clinical Laboratory Sciences, 52(2), 86-105. https://doi.org/10.3109/10408363.2014.992064
  2. Buttarello, M. (2016). Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? International Journal of Laboratory Hematology, 38(Suppl 1), 123-132. https://doi.org/10.1111/ijlh.12500
  3. Su, C., Liao, L. Z., Song, Y., Xu, Z. W., & Mei, W. Y. (2014). The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis. Journal of Thoracic Disease, 6(10), 1429-1440. https://doi.org/10.3978/j.issn.2072-1439.2014.09.10
  4. Tefferi, A., Hanson, C. A., & Inwards, D. J. (2005). How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clinic Proceedings, 80(7), 923-936. https://doi.org/10.4065/80.7.923
  5. Bhoopalan, S. V., Huang, L. J., & Weiss, M. J. (2020). Erythropoietin regulation of red blood cell production: from bench to bedside and back. F1000Research, 9, F1000 Faculty Rev-1153. https://doi.org/10.12688/f1000research.26648.1

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey